My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Abbott Laboratories (NY:ABT)

128.25 +4.28 (+3.46%)

Streaming Delayed Price Updated: 1:03 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

45 46 Next >

Top 2 Healthcare Stocks Every New Investor Should Know ↗

Today 8:15 EST

These healthcare stocks have long-term and profitable growth runways.

Via The Motley Fool

2 Fantastic Dividend Stocks to Buy and Hold Forever ↗

Today 5:47 EST

These companies have been raising their payouts for a combined 101 consecutive years.

Via The Motley Fool

Topics Intellectual Property

Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗

November 20, 2025

Via Stocktwits

Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗

November 20, 2025

On a big day for tech stocks, some other less well-known companies saw even larger moves.

Via The Motley Fool

Topics Artificial Intelligence Stocks

Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗

November 20, 2025

Via Stocktwits

Why Exact Sciences Rallied Over 50% This Week ↗

November 20, 2025

The company received a buyout offer from Abbot Labs.

Via The Motley Fool

Why Exact Sciences Stock Surged Today ↗

November 20, 2025

A healthcare giant covets the cancer screening leader's technology.

Via The Motley Fool

UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers

November 20, 2025

New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's...

Via MarketMinute

Topics Artificial Intelligence Economy

These S&P500 stocks are gapping in today's session ↗

November 20, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗

November 20, 2025

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.

Via Benzinga

Abbott To Acquire Exact Sciences For Up To $23B ↗

November 20, 2025

Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.

Via Stocktwits

Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗

November 19, 2025

A strategic investor is reportedly in advanced talks to purchase the company.

Via The Motley Fool

2 Healthcare Stocks Worth Your Attention and 1 We Ignore

November 19, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income ↗

November 15, 2025

Dividend stocks can strengthen your portfolio during any market environment.

Via The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

November 15, 2025

These stocks pay income that investors can count on over the long run.

Via The Motley Fool

Topics Intellectual Property

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

What Does the Market Think About Abbott Laboratories? ↗

November 14, 2025

Via Benzinga

Chicago Fed's 7th District Hiring Expectations Crash to -40: A Dire Signal for the Economy and Fed Policy

November 10, 2025

The economic outlook for the U.S. Midwest has taken a concerning turn as the Chicago Federal Reserve's 7th District hiring expectations index reportedly plummeted to -40 in October 2025. This alarming...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

2 Top Dividend Stocks to Buy and Hold Forever ↗

November 10, 2025

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

Via The Motley Fool

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & Supplies - Diversified Stocks

November 03, 2025

Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Abbott Laboratories (NYSE:ABT) and its peers.

Via StockStory

Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts

November 05, 2025

The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

AI's Power Problem ↗

November 03, 2025

AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast?

Via The Motley Fool

Topics Artificial Intelligence Economy Energy

ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat ↗

November 01, 2025

Via MarketBeat

Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook ↗

October 31, 2025

Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.

Via Investor's Business Daily

Should You Buy DexCom Stock Before Oct. 31? ↗

October 30, 2025

The company hasn't had a great year. Is it about to turn things around?

Via The Motley Fool

Topics Lawsuit

Recent Corporate Earnings Fuel Market Rally to Record Highs: AI and Rate Cut Hopes Drive Optimism

October 28, 2025

The third-quarter (Q3) 2025 earnings season has delivered a powerful jolt to global financial markets, propelling major U.S. indices to unprecedented record highs. A wave of surprisingly robust...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Is the Market Bullish or Bearish on Abbott Laboratories? ↗

October 28, 2025

Via Benzinga

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? ↗

October 28, 2025

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.

Via The Motley Fool

Topics Intellectual Property

Abbott Laboratories (NYSE:ABT): A Strong Dividend Stock for Reliable Income and Growth ↗

October 27, 2025

Discover Abbott Laboratories (ABT), a top dividend stock with a 1.87% yield, 11% growth, and a strong financial profile for reliable income.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.